Sirolimus-coated balloon shows 8-percentage-point advantage in three-year peripheral artery trial

RSS excerpt

Patients treated with sirolimus-coated balloons were more likely to remain free from repeat procedures to reopen blocked leg arteries than those receiving paclitaxel-coated balloons, according to three-year results from the SIRONA clinical trial presented at TCT 2026. While both treatments showed…